Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Other Operating Expenses (2012 - 2026)

Updated

Alnylam Pharmaceuticals' Other Operating Expenses was $298.45 million in Q2 2026, up 108.8% from $142.95 million a year earlier and up 41.4% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Other Operating Expenses (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Alnylam Pharmaceuticals' Other Operating Expenses was $977.45 million through Jun 30, 2026, up 142.7% year-over-year; for FY2025, it came in at $681.87 million, up 110.9% from FY2024.

  • Other Operating Expenses has now increased for five consecutive years, with a five-year compound annual growth rate of 54.3% (FY2020 to FY2025).
  • In earlier years, Other Operating Expenses was $323.37 million in FY2024 (+4.2%), $310.41 million in FY2023 (+83.9%), $168.82 million in FY2022 (+20.5%) and $140.14 million in FY2021 (+79.6%).
  • The Q2 2026 figure marks the highest quarterly Other Operating Expenses in data going back to Q4 2012.
  • Compared with a year earlier, Other Operating Expenses has increased for eight straight quarters, with growth averaging 92.1% over the last eight quarters.
  • The best year-over-year quarter for Other Operating Expenses over five years was Q1 2026 (growth of 197.2%); the worst was Q2 2024 (a decline of 19.6%).
  • Per Business Quant data, ALNY's Other Operating Expenses in the three quarters before Q2 2026 was $211.12 million (Q1 2026), $267.72 million (Q4 2025) and $200.15 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 298.45 Mn
Mar 31, 2026 211.12 Mn
Dec 31, 2025 267.72 Mn
Sep 30, 2025 200.15 Mn
Jun 30, 2025 142.95 Mn
Mar 31, 2025 71.04 Mn
Dec 31, 2024 102.82 Mn
Sep 30, 2024 85.91 Mn
Jun 30, 2024 68.67 Mn
Mar 31, 2024 65.98 Mn
Dec 31, 2023 85.86 Mn
Sep 30, 2023 84.31 Mn
Jun 30, 2023 85.37 Mn
Mar 31, 2023 54.87 Mn
Dec 31, 2022 51.27 Mn
Sep 30, 2022 41.12 Mn
Jun 30, 2022 40.81 Mn
Mar 31, 2022 35.63 Mn
Dec 31, 2021 37.66 Mn
Sep 30, 2021 32.66 Mn
API Access

Alnylam Pharmaceuticals Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ALNY&period=max&api_key=YOUR_API_KEY